Comparison of Ventro-Cephalic to Dorso-Caudal Translatoric Glides in Management of Cervicogenic Headache
NCT ID: NCT07006454
Last Updated: 2025-06-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
40 participants
INTERVENTIONAL
2024-07-18
2025-06-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
"Additional Effects of Sternocleidomastoid Release Along With Suboccipital Muscle Release in Management of Cervicogenic Headache'
NCT06731114
Cervical SNAG Half Rotation Technique in Cervicogenic Headache Patients.
NCT04788160
Manual Techniques in Cervicogenic Headache
NCT04954716
Effects of Garston Tool and Neuromuscular Reeducation in Cervical Headache
NCT05849545
Sustained Natural Apophyseal Glide and Deep Friction Massage in Patients With Cervicogenic Headache
NCT05404113
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A- Any headache fulling criterion C. B- Clinical and/or imaging evidence of lesion or disorder in cervical spine or soft tissues of neck that can cause headache.
C- Evidence of cause of headache demonstrated by at least 2 of these:
1. headache has developed in temporal relation to the onset of the cervical disorder or lesion.
2. headache has significantly improved or resolved in parallel with improvement in cervical lesion or disorder.
3. cervical range of motion is reduced, and headache is made significantly worse by provocative maneuvers.
4. headache is abolished following anaesthetic blocked of cervical structure. D- Not better accounted for by another ICHD-3 diagnosis.
CEH subject selection is based on clinical criteria, however anaesthetic blockades is not used as a criterion.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
Participants of group A will receive ventro-cephalic translatoric glide, total of 3 sets with 15 repetitions per set.
Duration (5 treatment sessions per week for 2 weeks)
Ventro-Cephalic Translatoric Glide
Participants of group A will receive ventro-cephalic translatoric glides, total of 3 sets with 15 repetitions per set.
PROCEDURE:
1. Patient sits on low chair with back straight and therapist stand facing the patient's right side.
2. Therapist's stable hand: with the thumb and index finger of left hand fixate caudal vertebra.
3. Therapist's moving hand: therapist will place his/her right hand on left side of patient's head and cervical spine than place little finger around cranial vertebra of segment to be moved.
4. Apply glide in ventro-cranial direction in the right angle of the treatment plane of the facet joint.
Group B
Participants of group B will receive Dorso-caudal translatoric glide, total of 3 sets with 15 repetitions per set.
Duration (5 treatment sessions per week for 2 weeks)
Dorso-Caudal Translatoric Glide
Participants of group B will receive Dorso-caudal translatoric glides, total of 3 sets with 15 repetitions per set.
PROCEDURE:
1. Patient sits on low chair with back straight and therapist stand facing the patient's left side.
2. Therapist's stable hand: with the thumb and index finger of right hand fixate caudal vertebra.
3. Therapist's moving hand: therapist will place his/her left hand on right side of patient's head and cervical spine than place little finger around cranial vertebra of segment to be moved.
4. Apply glide in dorso-caudal direction in the right angle of the treatment plane of the facet joint.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ventro-Cephalic Translatoric Glide
Participants of group A will receive ventro-cephalic translatoric glides, total of 3 sets with 15 repetitions per set.
PROCEDURE:
1. Patient sits on low chair with back straight and therapist stand facing the patient's right side.
2. Therapist's stable hand: with the thumb and index finger of left hand fixate caudal vertebra.
3. Therapist's moving hand: therapist will place his/her right hand on left side of patient's head and cervical spine than place little finger around cranial vertebra of segment to be moved.
4. Apply glide in ventro-cranial direction in the right angle of the treatment plane of the facet joint.
Dorso-Caudal Translatoric Glide
Participants of group B will receive Dorso-caudal translatoric glides, total of 3 sets with 15 repetitions per set.
PROCEDURE:
1. Patient sits on low chair with back straight and therapist stand facing the patient's left side.
2. Therapist's stable hand: with the thumb and index finger of right hand fixate caudal vertebra.
3. Therapist's moving hand: therapist will place his/her left hand on right side of patient's head and cervical spine than place little finger around cranial vertebra of segment to be moved.
4. Apply glide in dorso-caudal direction in the right angle of the treatment plane of the facet joint.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Both male and female A- Any headache fulling criterion C. B- Clinical and/or imaging evidence of lesion or disorder in cervical spine or soft tissues of neck that can cause headache.
C- Evidence of cause of headache demonstrated by at least 2 of these:
1. headache has developed in temporal relation to the onset of the cervical disorder or lesion.
2. headache has significantly improved or resolved in parallel with improvement in cervical lesion or disorder.
3. cervical range of motion is reduced, and headache is made significantly worse by provocative maneuvers.
4. headache is abolished following diagnostic blocked of cervical structure. D- Not better accounted for by another ICHD-3 diagnosis
Exclusion Criteria
18 Years
44 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Foundation University Islamabad
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Foundation University College of Physical Therapy
Islamabad, , Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FUI/CTR/2024/79
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.